More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$105.19B
EPS
3.57
P/E ratio
28.7
Price to sales
3.72
Dividend yield
3.515%
Beta
0.580559
Previous close
$77.95
Today's open
$80
Day's range
$79.87 - $82.83
52 week range
$73.31 - $106.33
show more
CEO
Geoffrey S. Martha
Employees
95000
Headquarters
Galway,
Exchange
New York Stock Exchange
Shares outstanding
1.28B
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research • 6 hours ago

3 High-Yielding Dividend Stocks That Just Raised Their Payouts
Lowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years. They offer above-average payouts and their valuations are also attractive.
The Motley Fool • 8 hours ago

Medtronic Bottoms, Healthy Rebound Ahead
Medtronic's NYSE: MDT primary catalyst as mid-year approaches is that headwinds are not impairing results as much as feared. Rising costs, margin compression, and general uncertainty linked to macroeconomic headwinds were reflected in the company's June 3 earnings results, but the results were inherently strong and expected to remain so.
MarketBeat • Jun 4, 2026

Wall Street May Be Mispricing Medtronic, Analyst Says
On Wednesday, Medtronic plc (NYSE:MDT) reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses.
Benzinga • Jun 4, 2026

MDT Q4 Earnings Call Points to Another Year of Growth
MDT touts FY26 as a turning point, keeps FY27 growth targets high, and spotlights CAS and new platforms as investors press on tariffs and TAVR.
Zacks Investment Research • Jun 4, 2026

Medtronic beats quarterly estimates on robust demand for heart devices
Medtronic beat Wall Street estimates for fourth-quarter revenue and adjusted profit on Wednesday, riding the wave of steady demand for its heart devices used in complex cardiac procedures.
Reuters • Jun 3, 2026

Medtronic Q4 Earnings Call Highlights
Medtronic NYSE: MDT reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations.
MarketBeat • Jun 3, 2026

Medtronic Posts Higher Profit, Sales
Medtronic said its profit and sales rose during its fiscal fourth quarter, reflecting steps the company has taken to improve business performance and drive growth.
WSJ • Jun 3, 2026

Medtronic Stock Rises on Earnings. Wall Street Looks Past a Soft Outlook.
The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts' estimates.
Barrons • Jun 3, 2026

Medtronic plc (MDT) Q4 2026 Earnings Call Transcript
Medtronic plc (MDT) Q4 2026 Earnings Call Transcript
Seeking Alpha • Jun 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medtronic plc. commission-free¹. Build wealth for the long term using automated trading and transfers.